diabetes drugs

Monetary benefits from value-based diabetes plans take timeValue-based insurance designs for diabetes care improve outcomes, but monetary gains may take years.
How Diabetic Kids and Teens Can Improve Quality of LifeGood glucose control can help children and teens with type 1 diabetes boost their quality of life.
Pharmacist Intervention Improves Diabetes Drug TrialsInterventions by pharmacists can help improve the results of diabetes clinical trials.
New FDA Warning on Canagliflozin
New FDA Warning on CanagliflozinStudies have linked type 2 diabetes drug to increased risk of foot and leg amputations.
Rising diabetes rates in children: Four things health execs should knowHere are four things MCOs should know about a new study focusing on young patients with diabetes.
New Programs Aim to Curb Diabetes Drug CostsDrug makers are starting plans to help patients pay for diabetes drugs.
Study: New Diabetes Drug Class Reduces Heart DeathsNew class of glucose-lowering agents lowers hospitalization and death rates even in Type 2 patients without heart disease.
Once-daily diabetes drug approvedFDA approved 10 mg dapagliflozin and 5 mg saxagliptin (Qtern, AstraZeneca), to treat type 2 diabetes.
New diabetes medications help address linked diseasesExperts share updates on new diabetes medications, and provide an overview of what’s coming.
Watch list 2017: Top therapeutic areas
Watch list 2017: Top therapeutic areasFind out about the latest treatment and drug pipeline developments